Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

AbelZeta Inc.

Clinical trials sponsored by AbelZeta Inc., explained in plain language.

Not yet recruiting 2 Not yet finished but already full! 1 Terminated 1

Engineered immune cells take on lupus kidney disease in early trial

Disease control Cancelled

This early-phase study tests a new treatment called C-CAR168 for people with lupus nephritis that hasn't improved with standard therapies. C-CAR168 is made from a patient's own immune cells, which are modified to target and attack faulty immune cells. The study will enroll 24 adu…

Phase 1/2 • Sponsor: AbelZeta Inc. • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC